Los Angeles, CA – January 2, 2013 - - WMI HOLDINGS (PINKSHEETS: WMIH) jumped up 1.14% to $0.89. The Company files(8-K) disclosing regulation FD disclosure, financial statements and exhibits. The 52-week range for the stock is $0.40 and $1.14. The Company has Price/Sales ratio of 0.05 and Price/Book ratio of 2.37. The 50-Day Moving Average and 200-Day Moving Average prices is $0.57 and $0.52 respectively. The Company together with its subsidiaries operates as a consumer and small business banking company in the United States.
Will WMIH Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=WMIH
Bio Matrix Scientific Group Inc (PINKSHEETS: BMSN) among the gainers and the stock is up 13.33% to $0.0017 on a traded volume of 8.19 million shares. The 52-week range for the stock is $0.02 and $0.18. The 50-Day Moving Average and 200-Day Moving Average prices is $0.03 and $0.04 respectively. The Company is in the business of designing, developing and marketing medical devices, specifically disposable instruments used in stem cell extraction and tissue transfer procedures and operating cryogenic cellular storage facilities, specifically stem cell banking facilities.
How Should Investors Trade BMSN After The Recent Momentum, Find Out Here http://beststocksdaily.com/p2/index.php?company=BMSN
Bergamo Acquisition Corp(PINKSHEETS: BGMO)soared 13.04% to $0.0260.The Company has received the OTC Markets "Current Information" designation and symbol. Bergamo Acquisition has filed its current financial statements and disclosure documents on the OTC Markets website.Bergamo Acquisition Corp is a global investor targeting a diversified portfolio of large corporate and middle-market companies for sole acquisition and co-investment.
Get Free Special Trend Analysis On BGMO Here http://beststocksdaily.com/p2/index.php?company=BGMO
Peregrine Pharmaceuticals(NASDAQ: PPHM) declined 2.44% to $1.20. Levi & Korsinsky LLP is investigating potential claims on behalf of purchasers of Peregrine Pharmaceuticals Inc securities concerning possible breaches of fiduciary duty in connection with the disclosure of the discovery of major discrepancies in the treatment group of its Bavituxmab Phase II Second-Line Non-Small Cell Lung Cancer Trial. Zacks increased the rating on the stock from a neutral to outperform in a research report. The firm currently has $1.50 price target on the stock.
Get Free Special Trend Analysis On PPHM Here http://beststocksdaily.com/p2/index.php?company=PPHM
Global Technologies Group Inc(PINKSHEETS: GTGP) is currently trading at $0.05.The Company reports results of the last meeting held at Oak Ridge National Laboratoryon September 12, which discussed the MBS technology for use at the Y12 complex. Global Technologies Groupis a company that is in the business of acquiring exclusive licenses and distribution and reseller contracts on proven technologies in the environmental, green and war fighter industries.
Get Free Special Trend Analysis On GTGP Here http://beststocksdaily.com/p2/index.php?company=GTGP
About Beststocksdaily
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
Disclaimer:
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Contact:
Brain Burr
Beststocksdaily
1419 Westwood Blvd Los Angeles, CA
90024-4911
staff@beststocksdaily.com
www.beststocksdaily.com
SOURCE Beststocksdaily